510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K081615Substantially Equivalent

Olympus Cea - Carcinoembryonic Antigen

OLYMPUS Corporation of the Americas, Co. Clare, IE / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K081615 is the FDA 510(k) clearance record for OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN, a class II device, cleared for Olympus America, Inc. on under FDA product code DHX (System, Test, Carcinoembryonic Antigen). FDA records list 150 510(k) clearances for OLYMPUS Corporation of the Americas, from to . As of , FDA records show no recalls naming K081615.

Clearance record

Decision date
Received
(282 days to decision)
Product code
DHX System, Test, Carcinoembryonic Antigen
Regulation
21 CFR 866.6010
Device class
Class II
Review panel
Immunology
Applicant
Olympus America, Inc. Lisheehan, O'Callaghan'S Mills, Co. Clare, IE
510(k) summary
Statement
Third party review
No

Clearances, product code DHX

Trailing 12 months

FDA records hold no clearances under product code DHX in the trailing twelve months.

FDA records show no clearances under product code DHX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DHX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260